Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromatin-remodeling ATPase INO80 (INO80) is the catalytic subunit of the multisubunit INO80 complex, a member of the SNF2 family of ATP-dependent chromatin remodelers[1][2][4]. INO80 features a Swi2/Snf2-type ATPase domain and unique insertion regions that organize the recruitment and assembly of other complex subunits[1][2]. The INO80 complex catalyzes chromatin remodeling through ATP-dependent nucleosome sliding and histone variant exchange, acting as a processive 'motor' that repositions nucleosomes and modulates DNA accessibility for transcription, repair, and replication[2][4]. It is essential for genomic DNA homeostasis, regulating promoter architecture, influencing gene expression, repairing double-strand DNA breaks, and facilitating replication fork progression[2][4]. Dysregulation of INO80 is implicated in cancer and other genomic stability disorders, but it is not yet a direct therapeutic target; efforts to modulate its function remain mostly preclinical[2].
Inhibition of ATPase or remodeling activity (if targeted)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromatin-remodeling ATPase INO80 (INO80).